715967

Hikma Pharmaceuticals USA, Inc. — FEI 2250102

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 25, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Eatontown, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
672821 CFR 314.80(b)Failure to review ADE information